A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Almac has undergone a successful inspection of its new US Commercial Packaging operations located in Audubon, Pennsylvania, by FDA. The inspection took place on Jan. 9–10, 2013 from which the regulatory body concluded that aforementioned site is fully compliant with GMPs, with no 483 issued. Read More
AMRI has signed an exclusive license agreement with Chai Therapeutics, an affiliate of Bessor Pharma, for the development of ALB 109564(a), AMRI’s tubulin inhibitor compound in late Phase I testing for treating cancer. The agreement follows the exercise of an option to license the intellectual property, which was granted in March 2012 by AMRI to Bessor Pharma, a translational drug development company. Read More
FDA has approved Celgene’s Pomalyst (pomalidomide) therapy new molecular entity for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy. Read More
Gilead Sciences completed its acquisition of YM BioSciences on Feb. 8, 2013. Read More
MeadWestvaco, a provider of packaging and packaging services, has expanded its pharmaceutical manufacturing Centre of Excellence, based in Hemer, Germany. The Centre is the core for MWV’s global pharmaceutical-dispensing systems manufacturing network. The $7.5-million project includes expanding cleanroom molding and assembly capacity, and the introduction of a logistics system to control the flow of finished goods and components. Read More
Pergamum and Cadila Pharmaceuticals have formed a collaboration to develop a treatment of infections with a targeting mechanism distinguished from classical antibiotics. The two companies will collaborate on the preclinical and clinical development of a novel therapeutic peptide that has been developed by Pergamum. The development will be conducted at the facilities of Cadila Pharmaceuticals in Ahmedabad, India. Cadila will be responsible for all costs related to the development of the product up to Phase II and global rights will be shared between the companies. Read More
Perrigo Company has completed the acquisition of Leeds, United Kingdom-based Rosemont Pharmaceuticals for approximately £180 million ($283 million) in cash. Read More
Pharmaceutical Product Development (PPD) has expanded its central laboratory testing services in infectious diseases. PPD has expanded its testing capabilities at its Brussels and Singapore laboratories, offering additional microbiology, peripheral blood mononuclear cell and molecular pathology services. Read More
Tranzyme’s board of directors has made a determination to explore and evaluate strategic alternatives, including the possibility of a merger, sale, other form of business combination, or other transaction to maximize value to its stockholders. Read More
UPS has expansded its global healthcare distribution network in five markets in North America. Expanding locations include facilities in Burlington, Ontario; Louisville, Kentucky; Mira Loma, California; Atlanta, Georgia; and Reno, Nevada. The new expansions add nearly 800,000-ft2 to UPS’s global network of 37 dedicated healthcare facilities, which now total nearly 6 million ft2 of distribution space. Read More
People News
BASi has named Jacqueline Lemke president and CEO. Read More
Mylan has appointed Melina Higgins and Rajiv Malik to its board of directors. Read More
Teva Pharmaceuticals has appointed Arie Belldegrun to its board of directors. Read More
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.